Science Magazine |
Federal officials pause trial testing stem cells for heart disease
Science Magazine The treatment has seemed safe in the 90 patients studied so far, said David Goff, director of NHLBI's Division of Cardiovascular Sciences. Many labs contributed to the basic research supporting the study, called CONCERT-HF, he said, not just the ... Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure - Full Text ... |
Tuesday, 30 October 2018
Federal officials pause trial testing stem cells for heart disease - Science Magazine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment